Results 231 to 240 of about 94,588 (272)

Intravitreal bevacizumab monotherapy for retinopathy of prematurity

Pediatrics International, 2013
AbstractBackgroundThe aim of this study was to evaluate the treatment outcomes of intravitreal bevacizumab (IVB) injections, used as a monotherapy in type 1 retinopathy of prematurity (ROP).MethodsA retrospective chart review was performed for 17 type 1 ROP patients (34 eyes), who had IVB injection between July 2011 and June 2012.
Alparslan, Şahin, Muhammed, Şahin, Abdullah Kürşat, Cingü, Yasin, Çınar, Fatih Mehmet, Türkcü, Harun, Yüksel, Savaş, Kaya, Şeyhmus, Arı, İhsan, Caça   +8 more
openaire   +2 more sources

Treatment of Coats’ disease with intravitreal bevacizumab

British Journal of Ophthalmology, 2012
To compare the efficacy of intravitreal bevacizumab plus ablative therapy with ablative therapy alone for Coats' disease.A retrospective review of all paediatric patients who received treatment for Coats' disease from a single surgeon (GBH) from 1 January 2001 to 31 March 2010 was performed.
Robin, Ray, David E, Barañano, G Baker, Hubbard   +2 more
openaire   +2 more sources

Efficacy of intravitreal bevacizumab after unresponsive treatment with intravitreal ranibizumab

Canadian Journal of Ophthalmology, 2011
To evaluate visual outcomes of eyes with choroidal neovascular membrane secondary to age-related macular degeneration that were initially treated with intravitreal ranibizumab then switched to intravitreal bevacizumab due to treatment failure.Retrospective chart review.Fifty eyes of 50 patients presenting to the Barnes Retina Institute.Patients ...
Arghavan, Almony, Azad, Mansouri, Gaurav K, Shah, Kevin J, Blinder   +3 more
openaire   +2 more sources

PREDICTED BIOLOGIC ACTIVITY OF INTRAVITREAL BEVACIZUMAB

Retina, 2007
To create a time- and dose-dependent mathematical model that compares the intravitreal vascular endothelial growth factor (VEGF) binding activity of bevacizumab with that of ranibizumab.Intravitreal half-lives and relative equimolar VEGF binding activities of bevacizumab and ranibizumab were incorporated into a first-order decay model.
openaire   +2 more sources

Intravitreal Bevacizumab for the Treatment of Retinal Angiomatous Proliferation

American Journal of Ophthalmology, 2007
To verify the potential efficacy of intravitreal bevacizumab (IVB) injections for the treatment of retinal angiomatous proliferation (RAP).Retrospective interventional case series.Four consecutive patients affected by RAP at different stages and refractory to photodynamic therapy (PDT). All patients underwent a complete ophthalmic examination including
COSTAGLIOLA, Ciro, ROMANO MR, DELL'OMO, Roberto, CIPOLLONE U, POLISENA P.   +4 more
openaire   +4 more sources

Intravitreal Bevacizumab in Aggressive Posterior Retinopathy of Prematurity

Ophthalmic Surgery, Lasers and Imaging Retina, 2007
<P>The anatomic response to intravitreal bevacizumab injection in three patients with aggressive, posterior retinopathy of prematurity is described. In all cases, the worse eye was treated with a single intravitreal injection of 0.75 mg of bevacizumab as monotherapy or complementary to laser therapy.
Travassos, A, Teixeira, S, Ferreira, P, Regadas, I, Travassos, AS, Esperancinha, F, Prieto, I, Pires, G, van Velze, R, Valido, A, Machado, MC   +10 more
openaire   +3 more sources

Intravitreal Bevacizumab

Ophthalmology, 2007
Raj S. Lucas, Hamish D.R. McKee, Lawrence R. Lee   +2 more
openaire   +1 more source

Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings.

Ophthalmology (Rochester, Minn.), 2017
D. Lepore, G. Quinn, F. Molle, L. Orazi, A. Baldascino, Marco H. Ji, M. Sammartino, F. Sbaraglia, D. Ricci, E. Mercuri   +9 more
semanticscholar   +1 more source

A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration

International ophtalmology, 2017
Dae Hyun Park, H. Sun, S. J. Lee
semanticscholar   +1 more source

Intravitreal Bevacizumab for Proliferative Sickle Retinopathy: A Case Series

, 2018
Cindy X. Cai, Marguerite O. Linz, A. Scott   +2 more
semanticscholar   +1 more source